SRSébastien Redon

Sébastien Redon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sébastien Redon has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Towards novel thiazolidine-2,4-diones. Synthesis, anticancer activity, DFT, and molecular docking

    by Hussein El-Kashef, Ilaria Lampronti, Omar Khoumeri, Redon Sébastien, Ahmed Mohamed, Al-Ahmady Ezzat, Chiara Tupini, Nadine Maria Barbieri, Patrice Vanelle, Nicolas Primas

    Two series of 3-substituted (Z)-5-(3,4,5-trimethoxybenzylidene)thiazolidine-2,4-dione derivatives were designed, synthesized, and evaluated for their anticancer potential. The first series (9a-f) incorporates carbamate moieties, whereas the second series (10a-e and 11a,b) contains urea functionalities. The synthetic route involved hydrolysis of the ester 4 into the corresponding acid 6, followed by conversion to the acid azide intermediate 8, and subsequent Curtius rearrangement in the presence of alcohols or amines to afford the target compounds. The antiproliferative activity of the synthesized derivatives was assessed against a panel of human cancer cell lines (MCF-7, MDA-MB-231, A2780, A2780cis, and K562), as well as the non-tumorigenic HaCaT cell line, using cisplatin as a reference drug. Several derivatives demonstrated promising cytotoxicity; in particular, the six compounds (9c, 9e, 9f, 10a, 10b, and 10c) exhibited IC50 values below 20 µM. Notably, compounds 9c, 9e, 10a, and 10b showed pronounced selectivity toward the aggressive triple-negative breast cancer MDA-MB-231 cell line, underscoring this scaffold as a promising platform for anticancer drug development. The urea derivatives 10a and 10b demonstrated superior activity compared with the carbamate analogues 9c and 9e. Compound 10b exhibited the highest activity (IC50 = 6.02±0.91 µM) and appeared as an MDA-MB-231 hit compound. Computational investigations, including DFT calculations and molecular docking, supported the experimental findings and suggested a multitarget mechanism of action.

  • Open Access

    Enhancing Antileishmanial Activity of Amidoxime-Based Compounds Bearing a 4,5-Dihydrofuran Scaffold: In Vitro Screening Against Leishmania amazonensis

    by Fabiana Maia Santos Urbancg Moncorvo, Oscar Leonardo Avendaño Leon, Christophe Curti, Youssef Kabri, Sébastien Redon, Eduardo Caio Torres-Santos, Patrice Vanelle

    Leishmaniasis, a protozoan disease affecting humans, exposes significant shortcomings in current treatments. In continuation to our previous findings on amidoxime-based antileishmanial compounds bearing a 4,5-dihydrofuran scaffold, twelve new amidoxime derivatives substituted at position 3 with an amide bearing a nitrogen heterocycle were synthesized. This series was designed to replace the sulfone and aryl group on a previously reported HIT. The synthesis of these compounds involved the following three-step pathway: manganese (III) acetate-based cyclization of a β-ketoester, followed by amidation with LiHMDS and a final reaction with hydroxylamine. Three of them, containing either bromine, chlorine, or methyl substitutions and featuring a pyridine moiety, showed an interesting toxicity–activity relationship in vitro. They exhibited IC50 values of 15.0 µM, 16.0 µM, and 17.0 µM against the promastigote form of the parasite and IC50 values of 0.5 µM, 0.6 µM, and 0.3 µM against the intracellular amastigote form, respectively. A selectivity index (SI) greater than 300 was established between the cytotoxic concentrations (in murine macrophages) and the effective concentrations (against the intracellular form of Leishmania amazonensis). This SI is at least seventy times higher than that observed for Pentamidine and twenty-five times higher than that observed for the reference HIT, as previously reported.

  • Open Access

    Hit-to-lead optimization of 4,5-dihydrofuran-3-sulfonyl scaffold against Leishmania amazonensis. Effect of an aliphatic moiety

    by Oscar Leonardo Avendaño Leon, Fabiana Maia Santos Urbancg Moncorvo, Christophe Curti, Youssef Kabri, Sébastien Redon, Patrice Vanelle, Eduardo Caio Torres-Santos


  • Open Access

    A simple N-heterocyclic carbene for the catalytic up-conversion of aldehydes into stoichiometric super electron donors

    by Nadhrata Assani, Ludivine Delfau, Preslav Smits, Sébastien Redon, Youssef Kabri, Eder Tomás-Mendivil, Patrice Vanelle, David Martin, Julie Broggi

    Catalytic amounts of 1,3-di(methyl)imidazole-2-ylidene, one of the simplest and most prototypical N-heterocyclic carbenes, can up-convert aldehydes into powerful stoichiometric sources of electrons (Super Electron Donors) for reductive transformations of iodoaryls (Ered < −2 V). In particular, the hydroarylation of 1,1′-diarylethylenes, which may require high temperatures and inherently generate stoichiometric amounts of oxidized waste, was performed at room temperature, with the concomitant formation of esters as oxidized co-products.


  • Open Access

    A Simple N-Heterocyclic Carbene for the Catalytic Up-conversion of Aldehydes into Stoichiometric Super Electron Donors

    by Nadhrata Assani, Ludivine Delfau, Preslav Smits, Sébastien Redon, Youssef Kabri, Eder Tomás-Mendivil, Patrice Vanelle, David Martin, Julie Broggi

    Catalytic amounts of 1,3-di(methyl)imidazol-2-ylidene, one of the simplest and most prototypical N-heterocyclic carbene can up-convert aldehydes into powerful stoichiometric sources of electrons (Super Electron Donors) for reductive transformations of iodoaryls (Ered <-2 V). In particular, the hydroarylation of 1,1’-diarylethylenes, which may require high temperatures and inherently generates stoichiometric amounts of oxidised wastes, was performed at room temperature, with the concomitant formation of esters as oxidated co-products.

  • Open Access

    Simple and green synthesis of 3‐acyl‐pyrazolo[1,5‐a]pyridines: [3+2] through cycloaddition of N‐aminopyridines on enaminones

    by Sébastien Redon, Patrice Vanelle

    A practicable method is described for the synthesis of 3‐acyl‐pyrazolo[1,5‐a]pyridines from N‐aminopyridines and easily available enaminones via a [3+2] cycloaddition. The reactions proceed well with a broad scope, without using additive (base or oxidant).


  • Open Access

    4-(5-Benzyl-3-((4-fluorophenyl)sulfonyl)-5-methyl-4,5-dihydrofuran-2-yl)-2-nitrobenzamide

    by Oscar Leonardo Avendaño Leon, Christophe Curti, Hussein El-Kashef, Youssef Kabri, Sébastien Redon, Patrice Vanelle

    As part of our ongoing attempt to broaden the applications of the amidoxime moiety as a potential source of new antileishmanial agents, this study focuses on the product 4-(5-Benzyl-3-((4-fluorophenyl)sulfonyl)-5-methyl-4,5-dihydrofuran-2-yl)-2-nitrobenzamide. This unexpected amide was obtained in an 85% yield as the major product with a conventional amidoxime synthesis protocol (Ethanol/Na2CO3) involving the reaction of hydroxylamine and a nitrile group. The formation of this amide derivative instead of the expected amidoxime can be attributed to two complementary effects: the strong electron effect of the nitro group and the influence of ethanol, a polar protic solvent. Alternatively, the desired amidoxime derivative, 4-(5-benzyl-3-((4-fluorophenyl)sulfonyl)-5-methyl-4,5-dihydrofuran-2-yl)-N′-hydroxy-2-nitrobenzimidamide, was obtained in an 80% yield by an alternative protocol (DMSO/KOtBu). This original compound, featuring a nitro group in the ortho position to the amidoxime, will be further evaluated, both in the field of medicinal chemistry and in other relevant areas, highlighting an unusual method to access amidoximes from hindered substrates.

  • Open Access

    Diethyl (5-Benzyl-2-(4-(N′-hydroxycarbamimidoyl)phenyl)-5-methyl-4,5-dihydrofuran-3-yl)phosphonate

    by Oscar Leonardo Avendaño Leon, Christophe Curti, Fabiana Maia Santos Urbancg Moncorvo, Youssef Kabri, Sébastien Redon, Eduardo Caio Torres-Santos, Romain Paoli-Lombardo, Patrice Vanelle

    As part of our ongoing research into the antileishmanial properties of amidoxime derivatives, we report a preliminary assessment of the antiparasitic properties of a novel compound, diethyl (5-benzyl-2-(4-(N′-hydroxycarbamimidoyl)phenyl)-5-methyl-4,5-dihydrofuran-3-yl)phosphonate. This compound was evaluated in vitro for the first time against the promastigote form of Leishmania amazonensis. Compounds containing both amidoxime and phosphonyl functional groups in dihydrofuran scaffolds are relatively rare, despite the extensive study of this heterocycle in various biological applications. Therefore, this work makes a valuable contribution to the fight against Leishmania spp. as a neglected disease. The cyclized 4,5-dihydrofuran intermediate scaffold was obtained via a three-step synthetic route that had previously been developed for accessing other derivatives, including the sulfone moiety. This synthesis was performed using a manganese-based free radical oxidative method under microwave irradiation. The intermediary 4,5-dihydrofuran, which included a nitrile group, tolerated the subsequent reaction with hydroxylamine hydrochloride, resulting in the formation of the target product. The target compound showed moderate activity in vitro against the promastigote form of L. amazonensis (IC50 = 91.1 µM).


  • Efficient Synthesis of Aminoquinolinium and Aminoquinazolinium Salt Series: Amination or N-Alkylation First?

    by Marion C. Casanova, Maximilien Fil, Patrice Vanelle, Julie Broggi, Yuxi Zhao, Nadine Azas, Sébastien Redon

    The pharmacokinetic properties and, in particular, the poor solubilities of lead drug compounds are often a major impediment to their future clinical development. One common and effective solution is generally to use salt forms. Efficient strategies for the synthesis of quinolinium and quinazolinium salt series with promising therapeutic activities are thus of major interest. This study compares different synthetic routes for the rapid preparation of monomeric and dimeric aminoquinolinium and aminoquinazolinium salts. The advantages and limitations of the different processes, especially the importance of step order, are discussed.